Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:39 PM
Ignite Modification Date:
2025-12-24 @ 11:39 PM
NCT ID:
NCT00464451
Eligibility Criteria:
Inclusion Criteria:
1. EEG study patients
2. Age less than 18 years
3. No contraindication for the use of chloral hydrate or dexmedetomidine
Exclusion Criteria:
1. Active, uncontrolled Gastroesophageal Reflux Disease (GERD)
2. Active, uncontrolled vomiting
3. Current history of apnea requiring apnea monitoring
4. Active, current respiratory issues that are different from the baseline status
5. Unstable cardiac status
6. Craniofacial anomaly with risk of inadequate bag-valve-mask ventilation
7. Current use of digoxin, betablockers, or calcium channel blockers
8. Current, active cerebral vascular disease
9. Patient treated with clonidine within the preceding one month
10. Prior history of drug reaction or sedation failure with either drug
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Months
Maximum Age:
18 Years
Study:
NCT00464451
Study Brief:
Protocol Section:
NCT00464451